These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26928855)

  • 1. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
    Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
    World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
    Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
    Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor of mediastinal lymph node metastasis of Siewert type I and II esophagogastric junction carcinomas.
    Nishiwaki N; Noma K; Matsuda T; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Langenbecks Arch Surg; 2020 Dec; 405(8):1101-1109. PubMed ID: 33155069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the surgical treatment strategies for Siewert type II squamous cell carcinoma in the same area as esophagogastric junction carcinoma: data from a single Japanese high-volume cancer center.
    Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
    Surg Today; 2014 Aug; 44(8):1522-8. PubMed ID: 24166133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
    Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
    Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting recurrence in patients with Siewert type II carcinoma treated with curative resection.
    Fukuchi M; Mochiki E; Suzuki O; Ishiguro T; Sobajima J; Onozawa H; Imaizumi H; Shibata K; Saito K; Naitoh H; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2015 Jan; 35(1):505-9. PubMed ID: 25550595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
    Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
    Anticancer Res; 2015 Jan; 35(1):445-56. PubMed ID: 25550586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Honda M; Kaito A; Daiko H; Kinoshita T
    Anticancer Res; 2014 Aug; 34(8):4391-7. PubMed ID: 25075076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of lymph node dissection in Siewert II adenocarcinoma of the esophagogastric junction.
    Tian Y; Lv H; Wang M; Tian Z
    J Cardiothorac Surg; 2024 Jul; 19(1):460. PubMed ID: 39026299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study.
    Ito H; Inoue H; Odaka N; Satodate H; Suzuki M; Mukai S; Takehara Y; Kida H; Kudo SE
    J Exp Clin Cancer Res; 2013 Jan; 32(1):2. PubMed ID: 23289488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
    Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
    Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
    Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
    Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.